MIAMI--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced financial results for the quarter ended March 31, 2009 (the “2009 Quarter”), reporting diluted earnings per share of $0.18 for the 2009 Quarter versus diluted earnings per share of $0.11 for the quarter ended March 31, 2008 (the “2008 Quarter”). Highlights of the 2009 Quarter included:
